EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Decoding Pancreatic Neuroendocrine Tumors: Molecular Profiles, Biomarkers, and Pathways to Personalized Therapy

Linda Galasso, Federica Vitale, Gabriele Giansanti iD, Giorgio Esposto, Raffaele Borriello, Irene Mignini, Alberto Nicoletti iD, Lorenzo Zileri Dal Verme, Antonio Gasbarrini iD, Maria Elena Ainora iD, Maria Assunta Zocco

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26167814 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Linda Galasso und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario Agostino, Gemelli IRCCS, Catholic University of Rome, 0016…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, Precision Medicine, Biomarkers, Tumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Roma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic neuroendocrine tumors (pNETs) are rare malignancies, accounting for 1–2% of pancreatic cancers, with an incidence of ≤1 case per 100,000 individuals annually. Originating from pancreatic endocrine cells, pNETs display significant clinical and biological heterogeneity. Traditional classification based on proliferative grading does not fully capture the complex mechanisms involved, such as oxidative stress, mitochondrial dysfunction, and tumor-associated macrophage infiltration. Recent advances in molecular profiling have revealed key oncogenic drivers, including MEN1 (menin 1), DAXX (death domain–associated protein), ATRX (alpha thalassemia/mental retardation syndrome X-linked), CDKN1B (cyclin-dependent kinase inhibitor 1B) mutations, chromatin remodeling defects, and dysregulation of the mTOR pathway. Somatostatin receptors, particularly SSTR2, play a central role in tumor biology and serve as important prognostic markers, enabling the use of advanced diagnostic imaging (e.g., Gallium-68 DOTATATE PET/CT) and targeted therapies like somatostatin analogs and peptide receptor radionuclide therapy (PRRT). Established biomarkers such as Chromogranin A and the Ki-67 proliferation index remain vital for diagnosis and prognosis, while emerging markers, like circulating tumor DNA and microRNAs, show promise for enhancing disease monitoring and diagnostic accuracy. This review summarizes the molecular landscape of pNETs and highlights genomic, transcriptomic, proteomic, and epigenomic factors that support the identification of novel diagnostic, prognostic, and therapeutic biomarkers, ultimately advancing personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeuroendocrine TumorsPrecision MedicineBiomarkers, TumorHumansReceptors, SomatostatinX-linked Nuclear Protein

Stichwörter der Autor:innen

alpha thalassemia/mental retardation syndrome X-linkeddeath domain-associated proteinmenin 1pancreatic neuroendocrine tumors

Substanzen

Biomarkers, TumorReceptors, SomatostatinX-linked Nuclear Protein

Autor:innen und Institutionen

  • Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario Agostino, Gemelli IRCCS, Catholic University of Rome, 00168 Rome, Italy.

ORCID-Profile: Gabriele Giansanti, Alberto Nicoletti, Antonio Gasbarrini, Maria Elena Ainora

Förderung

  • Fondazione Roma

Zitieren

APA

Galasso, L., Vitale, F., Giansanti, G., Esposto, G., Borriello, R., Mignini, I., Nicoletti, A., Zileri Dal Verme, L., Gasbarrini, A., Ainora, M. E., & Zocco, M. A. (2025). Decoding Pancreatic Neuroendocrine Tumors: Molecular Profiles, Biomarkers, and Pathways to Personalized Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167814

Vancouver

Galasso L, Vitale F, Giansanti G, Esposto G, Borriello R, Mignini I, et al. Decoding Pancreatic Neuroendocrine Tumors: Molecular Profiles, Biomarkers, and Pathways to Personalized Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167814

BibTeX
@article{Galasso2025,
  author = {Galasso, Linda and Vitale, Federica and Giansanti, Gabriele and Esposto, Giorgio and Borriello, Raffaele and Mignini, Irene and Nicoletti, Alberto and Zileri Dal Verme, Lorenzo and Gasbarrini, Antonio and Ainora, Maria Elena and Zocco, Maria Assunta},
  title = {Decoding Pancreatic Neuroendocrine Tumors: Molecular Profiles, Biomarkers, and Pathways to Personalized Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167814}
}
Kostenlos starten →